MAN1B1 antibody | knockout validation | Novus NBP2-13167
DOI
//dx.doi.org/10.13070/ko.en.7.2043
Date
2017-01-21

This is a knockout-validated antibody summary, based on the publication "ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG

Company: Novus

Antibody: MAN1B1

Catalog number: NBP2-13167

Summary: Mouse monoclonal IgG against full length human recombinant ERManI. Reacts with human and mouse protein by western blot, immunoprecipitation, immunocytochemistry, immunohistochemistry and ELISA.

Validation Method

Western blot

Sample

WT and ERManI-KO 293T cell clones.

Secondary incubation

Horseradish peroxidase-conjugated anti-mouse IgG (Pierce).

Detection

Enhanced chemiluminescence detection kit (Amersham Bioscience).

Figure

Please see Figure 5b in the article [1].

Clone note

The same clone (3C2) is sold as Novus Biologicals NBP2-13167, NBP2-13167AF405, NBP2-13167AF488, NBP2-13167AF647, NBP2-13167AF700, NBP2-13167B, NBP2-13167C, NBP2-13167F, NBP2-13167G, NBP2-13167H, NBP2-13167R, NBP2-13167V; OriGene TA336898.

References
  1. Zhou T, Frabutt D, Moremen K, Zheng Y. ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway. J Biol Chem. 2015;290:22184-92 pubmed publisher